{
    "2019-05-14": [
        [
            {
                "time": "2018-05-01",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "Rises",
                        "3%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "MC10, Inc. and AbbVie (NYSE:ABBV) Announce Clinical Trials in Multiple Sclerosis Using the BioStamp nPoint速 System",
                "features": {
                    "keywords": [
                        "Clinical Trials",
                        "Multiple Sclerosis",
                        "BioStamp nPoint速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-10",
                "original_text": "Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman",
                "features": {
                    "keywords": [
                        "U.S.-China trade war",
                        "Goldman"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global trade",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-20",
                "original_text": "AbbVie stock up 1.3% after announcing resolution to litigation over Humira in the U.S.",
                "features": {
                    "keywords": [
                        "stock up",
                        "litigation",
                        "Humira"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-12",
                "original_text": "AbbVie Resolves HUMIRA速 (adalimumab) U.S. Patent Litigation with Boehringer Ingelheim",
                "features": {
                    "keywords": [
                        "Resolves",
                        "HUMIRA速",
                        "Patent Litigation",
                        "Boehringer Ingelheim"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-14",
                "original_text": "AbbVie to Present at the UBS Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "Present",
                        "UBS Global Healthcare Conference"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}